The book discusses the institutional character of the Federal Circuit, as revealed by its first decade of decisions, as well as the Federal Circuit's recent decisions affecting the biotechnology industry. Also discussed are the court's decisions affecting pharmaceutical and plant and animal patents. An extensive subject matter index provides references to the court's decisions for legal and technical subjects, focusing on topics relating to biotechnology and chemical patent practice.